The latest news from Senzer

Please take some time to browse through our media section, Here, you’ll find Senzer’s latest and archived press releases, announcements and other media resources.

If you have any media-related enquiries please contact press@senzer.com.

News

Feb 20 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s ISO Certification: A First for the Pharmaceutical Cannabinoid Sector

In what is believed to be the first-ever ISO certification for the Design and Development of a medical device to deliver pharmaceutical-grade cannabinoids has been achieved by Senzer, the respiratory inhaler Company said today. Senzer said the award of ISO 13485:2016 certification, after a full evaluation of its Quality Management systems by the authorising body,...

Read More
Feb 11 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Publications

Quality World, February 2019 – Unlocking the potential of cannabinoids

Abstract: With medical cannabis receiving a high level of media interest in the past year, Senzer, a medical device and pharmaceutical company that focuses on inhaled cannabinoid therapies, tells Quality World how they are using an effective quality policy and quality management system to break new ground. In November 2018, medicinal cannabis was made available on...

Read More
Mar 19 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer Scoops a Second International Design Award

Senzer has won a leading international design award for its unique respiratory inhaler, its second such prize in a month, the pharmaceutical cannabinoid company, said today. Senzer's entry - its patented Systemic inhaled Delivery Device, SiDD™ is a winner of an iF Design Award in the Medicine/Health category. The competition run by the Hannover-based iF International Forum Design...

Read More
Feb 12 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Unique Pharmaceutical Inhaler Wins Prestigious Global Design Award

Senzer's unique breath-operated inhaler has won a leading global design award in which it was recognised for 'revolutionising the delivery of systemic medications through the lungs.' The GOOD DESIGN ® Awards, described as the oldest and most prestigious Global Awards Programme for design excellence and innovation, aims to honour 'products that have chartered new directions...

Read More
Jan 5 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

New Trial Data: Senzer’s Inhaler delivers cannabinoids faster at lower doses

The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer’s unique respiratory device is more than 50 times faster than oral delivery, at just a fraction of the dose, according to data released today under a clinical trial conducted in the US. Senzer, a UK-based drug delivery company, reported the success of a 36-subject pharmacokinetic...

Read More
Jul 5 2018
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer plans to launch its first inhaled cannabinoid products in the UK

Senzer Ltd has announced that it intends to launch its inhaled cannabinoid portfolio of products later this year in the UK under a specials pharmaceutical licence. This would enable doctors to prescribe its inhaled cannabinoid products to cancer patients undergoing chemotherapy. “Our delivery technology is a first of its kind – a respiratory delivery system...

Read More
Jul 5 2018
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

FDA accepts Clinical Research Plan to explore Senzer’s Inhaler for Cancer Patients

LONDON, UK – The US Food and Drug Administration have accepted an application for a clinical development study on Dronabinol Inhalation using Senzer’s unique breath-actuated inhaler, progressing the Company’s US partner, INSYS Therapeutics, on its path for approval of the device as an innovative approach to help cancer patients, Senzer said (today).

Read More